EVOGENE LTD (EVGN)
IL0011050551 - Common Stock
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product...
Evogene Announces Filing of Annual Report on Form 20-F
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product...
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel...
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evogene (NASDAQ:EVGN) just reported results for the fourth quarter of 2023.Evog...
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product...
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
/PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd. (Nasdaq:...
Evogene files for $200M mixed shelf offering (NASDAQ:EVGN)
Evogene files prospectus for $200M mixed shelf offering, clarifying it is not an offer to sell securities.
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel...
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
/PRNewswire/ -- AgPlenus Ltd, a global leader in designing and developing novel sustainable crop protection products, and a subsidiary of Evogene Ltd. (Nasdaq:...
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
/PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd. (Nasdaq:...
Evogene and Verb Biotics collaborate to advance probiotic innovation (NASDAQ:EVGN)
Evogene and Verb Biotics partner to develop probiotic bacteria that produce metabolites improving human health.
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development...
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Evogene Reports Third Quarter 2023 Financial Results
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based...
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results
/PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), and a leading ag-biologicals company that develops microbiome-based,...
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
Evogene Provides Operational Update Amidst Current Security Situation in Israel
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
Casterra delivers first shipment of castor seeds to Africa (NASDAQ:EVGN)
Casterra Ag announces the shipment of high-yield, high-oil castor seeds from Brazil and Zambia to Africa, fulfilling purchase orders worth $11.3M.
Casterra Delivers First Shipment of Castor Seeds to Africa
/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. ("Evogene") (Nasdaq: EVGN)...
Evogene Reports Second Quarter 2023 Financial Results
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery...
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...